Gemcitabine and cisplatin-induced tumor lysis syndrome in a patient with gallbladder carcinoma: A case report
- Authors:
- Deiter J. Duff
- Shadi Haddadin
- Carl Freter
- Chris Papageorgiou
View Affiliations
Affiliations: Department of Pathology and Anatomical Sciences, University of Missouri School of Medicine, Columbia, MO, USA , Department of Hematology and Oncology, University of Missouri School of Medicine, Columbia, MO, USA , SSM Cancer Care, St. Louis, MO, USA
- Published online on: February 12, 2013 https://doi.org/10.3892/ol.2013.1189
-
Pages:
1237-1239
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
We report a case of tumor lysis syndrome (TLS) in a patient with gallbladder carcinoma. TLS has not been reported in association with this type of tumor. TLS typically occurs in cases of highly proliferative hematological malignancies and small cell carcinoma. Two factors that may have contributed to TLS in this case include multifactorial mild acute renal failure shortly before the administration of chemotherapy and the aggressive morphology of the gallbladder carcinoma, which was a poorly differentiated sarcomatoid variant. This case raises concern for the development of TLS in certain types of patients with solid tumors.
View References
|
1
|
Coiffier B, Altman A, Pui CH, Younes A and
Cairo MS: Guidelines for the management of pediatric and adult
tumor lysis syndrome: an evidence based review. J Clin Oncol.
26:2767–2778. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baeksgaard L and Sorensen JB: Acute tumor
lysis syndrome in solid tumors – a case report and review of the
literature. Cancer Chemother Pharmacol. 51:187–192. 2003.
|
|
3
|
Huang WS and Yang CH: Sorafenib induced
tumor lysis syndrome in an advanced hepatocellular carcinoma
patient. World J Gastroenterol. 15:4464–4466. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cairo MS, Coiffier B, Reiter A and Younes
A: Recommendations for the evaluation of risk and prophylaxis of
tumour lysis syndrome (TLS) in adults and children with malignant
diseases: an expert TLS panel consensus. British J Haem.
149:578–586. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mughal TI, Ejaz AA, Foringer JR and
Coiffier B: An integrated clinical approach for the identification,
prevention, and treatment of tumor lysis syndrome. Cancer Treat
Rev. 36:164–176. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cairo MS and Bishop M: Tumour lysis
syndrome: New therapeutic strategies and classification. Br J
Haematol. 127:3–11. 2004. View Article : Google Scholar : PubMed/NCBI
|
